Core Viewpoint - The major shareholders of Jieya Co., Ltd. plan to reduce their holdings by up to 5.57 million shares, representing 4.95% of the total share capital, through block trades and centralized bidding within three months after the announcement [1] Summary by Category Shareholder Actions - The shareholders involved are Tongling Mingyuan Circular Economy Industry Venture Capital Fund Center (Limited Partnership) and its concerted party Suzhou Industrial Park Zhongyi Mingyuan Venture Capital Center (Limited Partnership) [1] - The planned reduction includes up to 2.7858 million shares through block trades and up to 2.7858 million shares through centralized bidding [1] Reduction Details - The reduction will take place within three months after the announcement, starting 15 trading days from the date of the announcement [1] - The selling price will be determined based on the market price at the time of the reduction [1] Reason for Reduction - The reason for the share reduction is stated as the shareholders' own management needs [1]

每经AI快讯，7月31日，洁雅股份（301108）(301108.SZ)公告称，公司持股5%以上股东铜陵明源循环经 济产业创业投资基金中心(有限合伙)及其一致行动人苏州工业园区中亿明源创业投资中心(有限合伙)计 划在本公告披露之日起15个交易日后的3个月内以集中竞价和大宗交易方式减持其持有的首次公开发行 前股份总数不超过5,571,534股，占公司总股本比例不超过4.95%。 ...

洁雅股份公告，持股5%以上股东铜陵明源循环经济产业创业投资基金中心（有限合伙）及一致行动人 苏州工业园区中亿明源创业投资中心（有限合伙）计划自公告披露之日起15个交易日后的3个月内，通 过集中竞价和大宗交易方式合计减持不超过557.15万股，占公司总股本不超过4.95%。其中，大宗交易 不超过278.58万股，集中竞价不超过278.58万股；明源基金拟减持不超过393.95万股，占3.50%，中亿明 源拟减持不超过163.21万股，占1.45%。 ...

证券代码：301108 证券简称：洁雅股份 公告编号：2025-057 铜陵洁雅生物科技股份有限公司 关于持股5%以上股东及其一致行动人减持股份计划 的预披露公告 持股 5%以上股东铜陵明源循环经济产业创业投资基金中心（有限合伙）及 其一致行动人苏州工业园区中亿明源创业投资中心（有限合伙）保证向本公司提 供的信息内容真实、准确、完整，没有虚假记载、误导性陈述或重大遗漏。 本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一致。 特别提示： 持股5%以上股东铜陵明源循环经济产业创业投资基金中心（有限合伙）（以 下简称"明源基金"）及其一致行动人苏州工业园区中亿明源创业投资中心（有 限合伙）（以下简称"中亿明源"）计划在本公告披露之日起15个交易日后的3 个月内以集中竞价和大宗交易方式减持其持有的首次公开发行前股份总数不超 过5,571,534股，占公司总股本比例不超过4.95%。 明源基金及其一致行动人中亿明源已获得中国证券投资基金业协会备案，申 请通过了适用创业投资基金股东的减持政策。截至首次公开发行上市日，投资期 限已满六十个月的，通过集中竞价和大宗交易方式减持股份总数不受比例限制。 铜陵洁雅生物 ...

证券之星消息，7月31日个护用品板块较上一交易日下跌1.99%，延江股份领跌。当日上证指数报收于 3573.21，下跌1.18%。深证成指报收于11009.77，下跌1.73%。个护用品板块个股涨跌见下表： 从资金流向上来看，当日个护用品板块主力资金净流出1.63亿元，游资资金净流出4671.12万元，散户资 金净流入2.1亿元。个护用品板块个股资金流向见下表： | 代码 | 名称 | 主力净流入(元) | 主力净占比 游资净流入 (元) | | 游资净占比 散户净流入 (元) | | 散户净占比 | | --- | --- | --- | --- | --- | --- | --- | --- | | 603059 | 倍加洁 | 2786.97万 | 9.56% | -2061.97万 | -7.07% | -725.00万 | -2.49% | | 001328 | 登康口腔 | 783.69万 | 6.75% | -633.61万 | -5.46% | -150.08万 | -1.29% | | 003006 自亚股份 | | 85.10万 | 0.53% | -742.19万 | -4.66% | ...

Group 1 - The company, Jieya Co., Ltd. (SZ 301108), announced that it will hold an investor research meeting on July 30, 2025, with participation from the Deputy General Manager and Board Secretary, Hu Nenghua [2] - For the year 2024, Jieya Co., Ltd.'s revenue composition indicates that the manufacturing of other daily chemical products accounts for 98.53% of total revenue, while other businesses contribute 1.47% [2]

Group 1 - The core viewpoint of the article highlights that Jieya Co., Ltd. (301108) has sufficient orders for its wet wipes business since the second quarter of 2025, indicating a stable order flow from existing customers [1] - The company has also secured additional business from key clients in the European and Canadian markets [1] - Jieya is actively expanding its market presence by targeting international brand clients in other regional markets [1]

人民财讯7月30日电，7月30日，洁雅股份（301108）在接待机构调研中表示，美国湿巾工厂项目目前处 在建设期，预计明年可以投产。美国工厂虽面临较高人工成本，但产品溢价空间较高，同时工厂将通过 引入自动化生产线和优化管理流程，实现运营效率提升和成本结构优化。 ...

Company Overview - Tongling Jieya Biotechnology Co., Ltd. was established in 1999, specializing in the research, production, and sales of wet wipes, with over 20 years of industry experience [1] - The company was listed on the Shenzhen Stock Exchange's Growth Enterprise Market on December 3, 2021, and is steadily advancing its fundraising projects [1] - In Q1 2025, the company reported a revenue of 124 million yuan and a net profit of 1,006.27 thousand yuan [1] U.S. Factory Development - The U.S. wet wipes factory is currently under construction and is expected to commence production next year [2] - To manage higher labor costs in the U.S., the factory will implement automated production lines and optimize management processes to enhance operational efficiency and cost structure [2] - Key investment risks for the U.S. factory include uncertainties in facility renovation and approval processes, customer audit outcomes, potential delays in production start, and cultural differences affecting production efficiency [2] Customer Relations and Market Strategy - The company primarily relies on forecast orders from clients, which are mostly well-known global enterprises, ensuring stable cooperation [3] - The company is focused on optimizing its business structure and enhancing core competitiveness through technological innovation [3] - The Shanghai R&D center is dedicated to independent research and development of cosmetic formulations and collaboration with domestic and international clients [3] Business Performance and Future Outlook - Since Q2 2025, the wet wipes business has seen a stable order flow, with existing clients maintaining orders and new business opportunities in Europe and Canada [4] - The company is actively expanding its market presence with international brand clients [4] - Future business drivers include expanding product categories and sales regions based on existing brand clients and leveraging the U.S. factory [4] Financial Management - The company has approximately 600 million yuan of idle fundraising capital allocated for principal-protected financial products, ensuring the safety of investments while supporting ongoing projects [4] - The company adheres to regulatory guidelines to prevent the disclosure of undisclosed significant information during investor communications [4]

Investment Rating - The report assigns a "Buy" rating for the company, indicating a positive outlook for the stock price in the next six months [5]. Core Insights - The company has launched a three-year incentive plan, granting 1.82 million shares, which is 1.62% of the total share capital, to ten key personnel, including executives [1]. - The company is a leading manufacturer in the wet wipes sector, ranking 4th, 9th, and 8th in China from 2021 to 2023 based on sales [2]. - Revenue has shown slight fluctuations from 2020 to 2024, with figures of 667 million, 623 million, and 547 million respectively, primarily due to changing demand post-pandemic [2]. - The company has a robust order book with major clients including Woolworths, Kimberly-Clark, Johnson & Johnson, and Procter & Gamble, and is actively expanding its international client base [2]. - Domestic production capacity is ramping up, with a projected annual capacity of 18.7 billion pieces by the end of 2024, while a new North American facility is set to begin production in Q1 2026 [3]. - Revenue projections for 2025-2027 are estimated at 743 million, 937 million, and 1.151 billion respectively, with corresponding net profits of 69 million, 83 million, and 108 million [4]. Financial Summary - The company reported a revenue of 623 million in 2023, with a projected decline of 12.07% in 2024, followed by a significant recovery of 35.8% in 2025 [4]. - The net profit for 2023 was 115 million, with a drastic forecasted drop to 19 million in 2024, but expected to rebound to 69 million in 2025 [4]. - The earnings per share (EPS) is projected to increase from 0.24 in 2024 to 0.96 in 2027, reflecting a positive growth trajectory [4].